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Abstract. At the University of Michigan the dermatologic 
surgeon works closely with the head and neck surgeon 
in resecting extensive cutaneous malignancies that could 
benefit from the combined skills of both surgical special- 
ists. Mohs surgery offers complete microscopic controlled 
resection of the cutaneous portion of skin cancers. Tu- 
mors extending deeply from the skin into underlying 
bone and soft tissue are resected with the assistance of 
the head and neck surgeon familiar with the anatomy and 
trained in the protection of the vital structures of the head 
and neck. It is evident that patients with large or aggres- 
sive basal cell carcinomas will best be served when this 
interdisciplinary approach has become commonplace. 
The past decade has increasingly demonstrated the 
advantage of an interdisciplinary team approach to 
the management of certain diseases of the head and 
neck. The head and neck surgeon has combined his 
skills with those of his neurosurgical colleagues to 
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perform craniofacial resections of tumors extending 
to regions of the anterior skull base. Likewise, 
neurotologists have teamed up with neurosurgeons 
to resect extensive posterior and middle cranial 
fossa tumors, which overall has resulted in im- 
proved function postoperatively. It is only logical 
that the Mohs surgeon seek the skills of the head 
and neck surgeon to assist him in resecting exten- 
sive facial skin cancers that extend into the nasal 
passage, paranasal sinuses, or orbital region.' Such 
extension may require the assistance of a head and 
neck surgeon to adequately remove the neoplasm 
extending into the deeper planes of the face and 
neck. Similarly, extensive facial skin cancers may 
invade deeply to involve the cranium and occasion- 
ally the underlying dura mater and brain. Such 
cases call for the assistance of surgeons trained in 
neurosurgery. 
At the University of Michigan the dermatologic 
surgeon works closely with the head and neck sur- 
geon in resecting extensive cutaneous malignancies 
that could benefit from combining the skills of both 
surgical specialists.2 Tumors requiring this multi- 
disciplinary approach are those demonstrating ag- 
gressive biologic behavior. Such tumors frequently 
occur in the "H" zone of the face (Fig. 1). This zone 
is noted for its high incidence of recalcitrant basal 
cell carcinomas (BCCs), and includes the central 
midfacial area including the upper lip, nose, and 
medial canthal regions. The zone extends horizon- 
tally to incorporate the lower eyelids extending to 
the preauricular area. The vertical portion of the 
"H' shaped zone of the facial skin is a large area 
of skin in the preauricular area extending superi- 
orly into the temple and inferiorly toward the angle 
of the mandible. This area also includes portions of 
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FIGURE 1. The "H"shaped zone of the face is noted for its high incidence of 
recalcitrant BCCs. 
the auricle and postauricular skin. The "H" zone 
represents a region where BCC tends to be more 
invasive and destructive and to recur more fre- 
q ~ e n t l y . ~  Thus, it is more difficult to treat skin can- 
cer in this region compared with similar tumors lo- 
cated in other sites about the face and neck. 
The apparent major reason for the aggressive- 
ness of skin cancers in the "H" zone is related to 
the fact that this region represents an area rich in 
embryologic fusion planes. Fusion planes are fre- 
quently perpendicular to the surface of facial skin 
and provide tissue interfaces for extension of tumor 
deeply toward underlying structures of the face.4 
When this occurs, i t  is best for the dermatologic 
surgeon to seek the assistance of a head and neck 
surgeon to facilitate resecting tumor involving 
bone, muscle, and vital structures. 
During the last 5 years, we have had extensive 
experience treating large facial skin malignancies by 
the interdisciplinary approach combining the skills 
of the dermatologic surgeon and the head and neck 
surgeon. The interdisciplinary approach allows for 
complete microscopic controlled excision of the tu- 
mor while maximizing conservation of tissue, and 
thus minimizing functional and cosmetic disability. 
The indications and techniques for the use of Mohs 
surgery in the treatment of skin cancer have been 
d e ~ c r i b e d . ~  The purpose of this paper is to present 
representative cases that exemplify the usefulness 
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of combining the surgical skills of these two sur- 
gical specialists. 
AURICULAR REGION 
In contrast to morpheaform BCCs that extend 
widely in a peripheral fashion, ulcerative BCCs 
tend to grow more deeply into the underlying 
structures of the face. BCCs occurring in the 
preauricular area are frequently of the ulcerative 
type and have a relatively high recurrence rate due 
to the tendency of the tumor to extend medially 
along the perichondrium of the external auditory 
canal.5 Robins6 reports the preauricular area as hav- 
ing statistically significantly higher recurrence rates 
following controlled microscopic excision of BCC 
compared with other anatomic regions of the face. 
The aggressive nature of BCC involving the pre- 
auricular area is represented by the patient in Fig- 
ure 2. This patient presented with a neglected ul- 
cerative BCC of the preauricular skin. Figure 2 also 
demonstrates the skin defect following adequate re- 
moval of the tumor from the skin of the preau- 
ricular region. However, tumor extended medially 
in the subperichondrial plane of the cartilaginous 
external auditory canal toward the bony canal. Tu- 
mor extended beyond the confines of the canal an- 
teriorly and necessitated a parotidectomy with 
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FIGURE 2A. Neglected ulcerative BCC of the preauricular 
skin. 
FIGURE 2B. Skin defect following Mohs excision of 
tumor. 
FIGURE 2C AND D. Extension of tumor medially required removal of the entire condyle of the mandible and the tympanic 
bone except bony anulus. Defect was covered with a split-thickness skin graft. One year postoperative. 
preservation of the facial nerve. Extension of tumor with removal of the cartilaginous and bony external 
medially toward the tympanic membrane required auditory canal. In such instances, the surgical ap- 
removal of the entire condyle of the mandible and proach is accomplished by making a standard tym- 
tympanic bone down to, but not including, the panomeatal flap and elevating the skin of the ex- 
bony anulus. ternal canal away from the anulus. Following skin 
Extensive BCCs extending into the auditory elevation, the most medial aspect of the flap is sam- 
canal sometimes require radical mastoidectomy pled by the dermatologic surgeon to evaluate the 
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FIGURE 3A AND B. Following Mohs excision of BCC of the preauricular area necessitating removal of the left parotid 
gland and  sacrifice of the facial nerve. 
FIGURE 3C. Defect reconstructed with postauricular skin 
flap. 
medial surgical margin. Should tumor be noted at 
the extreme medial aspect of the flap, it is recom- 
mended that the patient undergo removal of the 
tympanic membrane, annular ligament, and radical 
mastoidectomy. At the time of tympanic membrane 
removal, the mucous membrane in the middle ear 
medial and adjacent t o  the anulus is sampled and 
FIGURE 3D. Nine months postoperative. 
examined for foci BCC. If the presence of tumor is 
documented in the middle ear, consideration must 
be given to a formal temporal bone resection or the 
utilization of postoperative radiotherapy. 
Patients with BCC extending deeply from the 
preauricular area requiring removal of the external 
ear canal should probably be observed from 12 to 
/. Dermatol. Surg .  Oticol. 23:lO October 2987 1098 
BAKER ET AL 
18 months by surfacing the area with a split-thick- 
ness skin graft rather than subjecting them to im- 
mediate reconstruction using a local or regional 
flap. This is particularly true if there is concern for 
the adequacy of surgical margins around the neo- 
plasm. The thin covering offered by the skin graft 
may permit early detection of recurrent neoplasm 
(Fig. 2). 
Figure 3 represents a patient that developed BCC 
of the preauricular area necessitating removal of the 
left parotid gland and sacrifice of the facial nerve. 
Tumor extended onto the zygomatic arch, and sam- 
pling of the periosteum by the dermatologic sur- 
geon demonstrated tumor involvement. Tumor was 
noted to extend to the deep aspect of the zygomatic 
arch. Working with the assistance of the dermato- 
logic surgeon who provided histologic assessment 
of the surgical margins, the head and neck surgeon 
removed the entire arch as well as the upper por- 
tion of the masseter muscle. It was the consensus 
of the surgeons involved that surgical margins were 
adequate to allow immediate reconstruction of the 
defect. The defect was reconstructed utilizing a 
cervical flap based inferiorly and harvested from 
the postauricular area. 
A postauricular cervical cutaneous flap is advan- 
tageous for reconstruction of defects in the preau- 
ricular area because it provides the best color and 
texture match with that of the skin of the remaining 
cheek and forehead regions (Fig. 3). Another ad- 
vantage is that the secondary defect, although often 
requiring a split-thickness skin graft to facilitate clo- 
sure, is located in the postauricular area which is 
helpful for scar camouflage and overall cosmesis. 
Whenever it is necessary to sacrifice the facial 
nerve in order to completely remove a BCC, at- 
tempts should be made to graft the portion of re- 
sected nerve. However, frequently tumors located 
in the preauricular area extend peripherally to such 
a degree that the distal branches of the facial nerve 
have to be sacrificed in order to ablate all of the 
tumor. Such instances preclude any attempt to 
reanimate the face by cable nerve grafting. Unfor- 
tunately, in most of these cases, there is a frequent 
need to remove the masseter muscle and portions 
of the temporalis muscle, thus precluding the pos- 
sibility of rehabilitating the face with a dynamic 
sling. The only alternative in such cases may be the 
use of static fascia lata slings to suspend the oral 
commissure in a more symmetrical position. 
Similar to BCCs arising in the preauricular skin, 
tumors occurring in the postauricular sulcus often 
grow in an aggressive manner extending through 
the concha1 cartilage as well as spreading into the 
external auditory canal. However, tumor spread 
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tends to be more in a superior and inferior direc- 
t i ~ n . ~  Tumor may spread inferiorly to involve the 
sternocleidomastoid muscle and deeper structures 
of the upper neck or spread medially to involve the 
cortex of the mastoid bone. Ceilley et al.7 reported 
a higher than usual recurrence rate in treating au- 
ricular BCCs and noted the frequent aggressiveness 
of tumors occurring in the postauricular region. 
Ulcerative tumors located in the inferior aspect 
of the postauricular sulcus often extend inferiorly 
to involve the sternocleidomastoid muscle, tail of 
the parotid gland, and deeper structures of the 
neck.5 A representative case is shown in Figure 4. 
The patient presented with a recurrent ulcerative 
BCC of the lower postauricular sulcus that ex- 
tended into the deep structures of the upper neck, 
necessitating a regional neck dissection confined to 
the upper posterior cervical triangle in order to ir- 
radicate the entire tumor. In patients requiring 
parotidectomy or regional neck dissection, the head 
and neck surgeon performing the operation has re- 
lied on the dermatologic surgeon to assist him in 
surveying all of the deep soft tissue margins, thus 
ensuring that all tumor has been eradicated from 
the deeper tissue planes of the neck. In this in- 
stance, the tail of the parotid gland, posterior di- 
gastric muscle, and upper sternocleidomastoid 
muscle were all histologically examined to ensure 
adequacy of tumor ablation in tissue planes deep to 
the skin (Fig. 4). 
Along with location of BCCs, tumor histology 
plays an important role in the treatment of these 
cutaneous neoplasms. The more common tumor 
histologies (noduloulcerative, superficial) represent 
little problem in the diagnosis and treatment, par- 
ticularly if the tumor is small and occurs outside 
of the "H' zone of the face. Those tumors with 
aggressive histologic behavior, however, often 
warrant a more exacting treatment of microscopic 
controlled resection. These histologic subgroups in- 
clude the morpheaform or sclerotic BCC, multicen- 
tric infiltrating tumor, and the aggressive keratin- 
izing BCC (basosquamous carcinoma or metatypical 
carcinoma). 
A higher than usual recurrence rate for mor- 
pheaform BCC, even after treatment by Mohs tech- 
nique, has been reported. This may result from sub- 
tle subclinical extension and possibly from stromal 
dependence of this tumor. Salasche and Amonettes 
found subclinical extensions to average 7.2 mm in 
51 morpheaform BCCs. They noted that the great- 
est degree of subclinical extension occurred in the 
preauricular region. Ceilley et al.7 found that of 
their inadequately excised BCCs of the ear, the mor- 
pheaform type was the most common. 
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FIGURE 4A. Recurrent ulcerative BCC postauricular FIGURE 48. Following Mohs excision of cutaneous por- 




FIGURE 4C. Mohs surgical margin specimen following re- 
gional neck dissection, necessary to extirpate tumor ex- 
tending deeply in the neck. This specimen represents the 
interface between the resected tumor and remaining nor- 
mal tissues in the neck. Specimen was used for complete 
histologic control of surgical margin. 
Figure 5 demonstrates a morpheaform BCC in- 
volving the preauricular skin. Surgical excision uti- 
lizing microscopic controlled resection necessitated 
removal of the posterior facial skin, most of the skin 
of the upper neck and postauricular area, as well 
1100 
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FIGURE 4D. Defect following upper posterior neck dis- 
section. 
as a large portion of the scalp located in the occipital 
area. This case nicely demonstrates the massive 
subclinical extension that can occur with morphea- 
form BCCs. It also demonstrates the usefulness of 
an interdisciplinary approach for the management 
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FIGURE 5A. Morpheaform BCC of periauricular skin. FIGURE 5B. Defect following Mohs excision. 
of extensive cutaneous malignancies. The derma- 
tologic surgeon can ensure adequacy of resection 
margins and the head and neck surgeon can pro- 
vide technical assistance in resection of deep tissues 
and reconstruction of the ablative defect following 
ablative surgery. 
Figure 6 demonstrates another patient suffering 
from a histologically aggressive tumor. The neo- 
plasm presented as a keratotic (basosquamous) 
BCC located in the postauricular area with exten- 
sion into the parotid gland. The patient required a 
radical parotidectomy and sacrifice of the facial 
nerve and facial nerve cable grafting. Because of the 
aggressiveness of the tumor, it was elected to ad- 
minister postoperative radiotherapy, although all 
surgical margins were free of residual tumor. 
The decision to combine postoperative radio- 
therapy with microscopically controlled surgical ex- 
cision of extensive skin cancers is a matter of clinical 
judgment based on the size and location of tumor 
and the histology of the cancer. We have treated a 
small select group of patients suffering from BCC 
with postoperative radiation therapy in specific in- 
stances where recurrent tumor required extensive 
resection of the facial soft tissues and where sur- 
gical margins of normal tissue were not as abun- 
dant as we would desire. More specifically, post- 
operative radiotherapy has been used to treat 
potentially persistent microscopic disease in cases 
where cancer encroached on regions of the skull 
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base such as the glenoid fossa, jugular foramen, 
cribiform plate, and the middle skull base. 
CENTRAL FACE 
Mora and Robins’ showed that BCC in the central 
face, similar to those located in the para-auricular 
areas, tend to be more invasive, more destructive, 
and more recurrent than similar tumors located at 
other sites of the head and neck. The junction of 
the nasal ala with the upper lip and facial skin of 
the cheek represents an important embryologic fu- 
sion plane where BCCs may extend deeply into the 
underlying structures of the face including the na- 
sal passage and paranasal sinuses. Tumor may also 
demonstrate subclinical extension along the peri- 
chondrium of the upper and lower lateral nasal car- 
tilages into the depths of the nasal vestibule neces- 
sitating full-thickness resection of portions or of all 
the nasal tip and ala.’O 
A limited maxillectomy is occasionally required 
when midfacial skin cancer involves the pyriform 
aperture of the nose. This occurs when neglected 
or recurrent BCCs occurring in the nasolabial crease 
and upper lip spread laterally along the periosteum 
covering the face of the lower maxilla. Neoplastic 
cells may also spread inward along the lateral wall 
of the nose, often beneath the inferior turbinate. 
When this occurs, the preferred treatment is com- 
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FIGURE 6A. Cutaneous malignancy of periauricular area. FIGURE 68. Complete resection of tumor required radical 
parotidectomy, sacrifice of the facial nerve and facial 
nerve cable graft. 
FIGURE 7. Cutaneous malignancy extending deeply into 
the lateral nasal passage may require complete removal 
of the bony structures in the vicinity of the nasal apper- 
ture. 
plete removal of the bony structures in the vicinity 
of the nasal aperture. The anterior lateral wall of 
the nose and the medial aspect of the face of the 
maxilla are completely removed along with the in- 
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ferior aspect of the lacrimal duct and the anterior 
one-half of the inferior turbinate (Fig. 7). In addi- 
tion to removal of the lateral aspect of the nose, a 
portion or all of the premaxilla may require re- 
moval. Such resections are facilitated by the coop- 
erative efforts of the dermatologic surgeon and the 
head and neck surgeon. 
Nasal passage and paranasal sinus involvement 
with facial skin cancer occurs not only as a result 
of neglected or recurrent BCC, but when tumors are 
biologically aggressive and are located in the mid- 
facial region. Reconstruction after controlled micro- 
scopic surgical ablation of such neoplasms should 
be delayed 12 to 18 months in most instances to 
provide an opportunity for any persistent carci- 
noma to manifest itself. In the interim, the surgical 
defect can be covered with a split-thickness skin 
graft. A prosthesis can be manufactured to assist in 
the cosmetic and functional rehabilitation of the 
patient, and can be used until reconstruction is 
deemed advisable. 
BCC occurring in the superior portions of the 
midface occur most frequently in the region of the 
medial canthus. Tumors located near the medial 
canthus of the eye may extend deeply into the orbit 
or the anterior ethmoid sinuses, necessitating re- 
section of part or of all of the orbital contents and 
ethmoidectomy . 
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FIGURE 8A. Following Mohs excision of recurrent basal 
cell carcinoma. 
FIGURE 88. Complete microscopic excision required bi- 
lateral ethmoidectomy and resection of the nasal bones 
and lamina papyracia. 
Figure 8 represents a patient following Mohs ex- 
cision of a recurrent BCC located in the region of 
the medial canthal and glabella regions. At the time 
of complete microscopic excision, tumor was noted 
to involve the periosteum of the nasal bones and 
the lamina papyracia bilaterally. An interdiscipli- 
nary approach combining the skills of the derma- 
tologic surgeon and the head and neck surgeon 
provided the best opportunity for complete eradi- 
cation of disease by removing the nasal bones and 
the lamina papyracia bilaterally along with the up- 
per portion of the nasal septum. The extensiveness 
of the tumor and the history of recurrent disease 
called for delay of the reconstruction for a period 
of 18 months to provide ease in observing the re- 
gion for possible persistent tumor. Indeed, the pa- 
tient developed a recurrence in the skin adjacent to 
the nasal defect 1 year after our attempt to cure him 
of his tumor. 
Tumors occurring in the midfacial skin may track 
along the infraorbital nerve to involve the maxillary 
sinus or orbit and may extend as far posteriorly as 
the foramen rotundum. An example of this is seen 
in Figure 9, which demonstrates a surgical speci- 
men consisting of the maxilla and contents of the 
orbit. Orbital exenteration was necessary because a 
recurrent BCC of the facial skin had extended along 
the infraorbital nerve into the maxillary antrum and 
orbit regions. Tumor invaded the orbital fat and ex- 
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traocular muscles to such a degree that it was not 
possible to preserve the ophthalmic globe. Tumor 
also tracked along the infraorbital nerve posteriorly 
toward the foramen rotundum. Following maxillec- 
tomy, frozen section analysis of the nerve exiting 
the foramen demonstrated malignant cells. Thus it 
was elected to treat the patient with postoperative 
radiotherapy. Unfortunately, the patient developed 
recurrent disease at the skull base and eventually 
died of his cancer. 
This case exemplifies the need for appropriate 
radiographic studies preoperatively in instances 
where the clinician is concerned about deep exten- 
sion of tumor toward the paranasal sinuses. I t  is 
also a good example of the aggressiveness mani- 
fested by some BCCs occurring in the midfacial re- 
gion and the need on occasion to use radiation ther- 
apy as an adjunct to surgical excision of extensive 
skin cancers. 
SCALP 
BCCs of the scalp tend to occur most commonly in 
the temple area and may extend deeply to involve 
the underlying periosteum, temporalis muscle, and 
calvarium. Extensive tumors may require removal 
of a large portion of the scalp overlying the frontal 
and parietal bones. The underlying periosteum is 
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FIGURE 9. Surgical specimen consisting of the maxilla 
and contents of orbit. BCC involved the entire length of 
the infraorbital nerve and invaded the orbital fat and ex- 
traocular muscles. (E) Eye. (A) Antrum. (T) Tumor in- 
volving infraorbital nerve. 
frequently involved with neoplasm necessitating 
removal, thus making reconstruction of such de- 
fects more difficult. In instances where periosteum 
is involved with tumor but no gross tumor is noted 
to involve the calvarium, the bone is treated by sur- 
gical removal of the exterior portion utilizing a ro- 
tating cutting burr. It is difficult for a skin graft to 
heal on bare bone and it may take many months for 
the defect to granulate and heal by second inten- 
tion. This is true in spite of drilling holes through 
the outer cortical bone to facilitate the growth of 
granulation tissue from the more vascular medul- 
lary portion of the calvarium. 
Large areas of exposed bone are best treated by 
rotating a local scalp flap to cover the exposed 
bone." The scalp flap is elevated in a plane super- 
ficial to the periosteum so that the secondary defect 
can be closed with a split-thickness skin graft if nec- 
essary, or on occasion, may be closed primarily by 
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local advancement of surrounding scalp tissue. Pri- 
mary closure is aided by performing incisions 
through the galea parallel to the major vascular 
supply to the scalp to enhance stretching of the 
flap. 
Large neglected ulcerative BCCs of the scalp not 
infrequently invade the underlying calvarium. Tu- 
mors that grossly invade the outer cortex of the cal- 
varium require wide full-thickness resection of the 
cranium. When bone involvement is suspected by 
the clinician, the patient should be evaluated pre- 
operatively with appropriate radiographic studies 
including polytomography or CAT scan analysis to 
assess the cranial bone and underlying brain. Ex- 
tensive involvement with BCC of cranial bone ne- 
cessitates well-conceived preoperative planning by 
the surgical disciplines involved with treating such 
patients. 
Frequently, the dermatologic surgeon will seek 
the assistance of the head and neck surgeon and 
the neurosurgeon in resecting such tumors. The 
multidisciplinary team must be prepared to trace 
the tumor as deep as necessary in order to eradicate 
all neoplasm. This may require multiple frozen sec- 
tions to assess the parameter of the scalp defect, as 
well as the surgical margins of the dura mater and 
occasionally the brain itself. The dermatologic sur- 
geon has the capability of processing bone within 
24 hours so that bony margins can be readily as- 
sessed for the possibility of tumor involvement. 
When a bony margin is found to contain tumor, the 
patient is returned to the operating room the next 
day for additional bone removal. 
An example of the interdisciplinary approach for 
the treatment of large tumors of the scalp is rep- 
resented in Figure 10. The skills of the dermatologic 
surgeon and the head and neck surgeon were com- 
bined with those of a neurosurgeon to completely 
eradicate a neglected BCC involving the postau- 
ricular scalp. Tumor extended into the mastoid cor- 
tex necessitating a modified radical mastoidectomy, 
removing all of the cortex of the mastoid bone. For- 
tunately, tumor did not extend into the air cells of 
the mastoid and thus the facial nerve and hearing 
were spared. Tumor also extended full thickness 
through the posterior calvarium and into the un- 
derlying dura mater in the vicinity of the lateral 
sinus. 
Tumor invasion of the dura mater over the sinus 
necessitated removal of the sinus, as well as a large 
area of dura mater. Complete microscopic survey 
of the deep surface of the resected dura mater dem- 
onstrated no evidence of penetration of tumor into 
the underlying brain. The defect in the dura mater 
was repaired with a fascia lata graft and the dural 
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FIGURE 10A. BCC of occipital scalp. 
FIGURE 10D. Calverium and fascia1 graft were covered by 
a medially based shoulder flap. Six weeks postoperative. 
FIGURE 10B. Scalp specimen demonstrating multiple sec- 
tions necessary to provide complete microscopic control 
of the surgical margin of the scalp. 
FIGURE 1OC. Tumor invasion of the dura mater over the 
lateral sinus necessitated removal of the sinus as well as 
a large area of the dura mater. Fascia1 graft for repair of 
the dura is attached inferiorly. 
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graft and surrounding exposed calvarium were cov- 
ered with a medially based shoulder flap. 
This case highlights the importance of combining 
the skills of various surgical disciplines to maximize 
the opportunity of eradicating extensive facial skin 
malignancies that involve the head and neck region 
while at the same time providing for the reconstruc- 
tion of the resulting defect, thus limiting functional 
impairment. 
CONCLUSION 
The usefulness of an interdisciplinary approach 
combining the skills of the dermatologic surgeon 
and the head and neck surgeon for the manage- 
ment of extensive BCCs of the head and neck is well 
founded in our experience. The Mohs surgical tech- 
nique offers meticulous marginal control for a va- 
riety of cutaneous, as well as paracutaneous neo- 
plasms, with the advantage of conserving normal 
surrounding tissues and structures. Tumor extend- 
ing deeply from the skin into underlying bone and 
soft tissue is resected with the assistance of a head 
and neck surgeon familiar with the anatomy and 
trained in the protection of the vital structures of 
the head and neck. The skills of the neurosurgeon 
are necessary when cancer invades or encroaches 
upon the central nervous system. It is evident that 
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patients with large or aggressive BCCs will best be 
served when this interdisciplinary approach has be- 
come commonplace. 
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Treatment of Chromomycosis with Liquid Nitro- 
gen. JA de Souza Sittart, NY Valente. Med Cutan 
Iber Lat Am 14:227-232, 1986 (Portuguese). 
Five patients with chromomycosis of the legs from 
the S5o Paulo area, Brazil, after unsuccessful at- 
tempts of treatment with amphotericin B, 5-fluoro- 
citosine, and ketoconazole, were successfully 
treated by several applications of liquid nitrogen, 
with healing accompanied by cicatricization. The 
evolution of the disease had been from 1 to 25 
years. Four patients had verrucous patches and one 
patient a sarcoid-like lesion. All patients were cul- 
ture positive for Fonseca pedrosi. There has been 
no recurrence during a 2 to 4 year follow-up. 
YEHUDI M. FELMAN, M.D. 
Retinoids and Systemic Chemotherapy in Cases of 
Advanced Mycosis Fungoides. A Report from the 
Scandinavian Mycosis Fungoides Group. L 
Molin, K.  Thomsen, G Volden, et al. Acta Derm 
Venereol 67:179-183, 1987. 
Effective therapy for advanced stage mycosis fun- 
goides (MF) is lacking. The authors report their re- 
sults in 8 patients treated with a combination of 
bleomycin, cyclophosphamide, and prednisolone 
and in 12 patients who were treated with these 
three drugs plus either etretinate (11 patients) or 
13-cis-retinoic acid (1 patient). All 20 patients had 
tumor stage MF, and 14 patients had extracuta- 
neous disease. Of the 8 patients receiving combi- 
nation chemotherapy, 5 showed a partial or com- 
plete remission, with a median remission of 3 
months. In the patients treated with retinoids, 7 
showed a partial or complete response lasting a me- 
dian of 6 months. The side effects observed were 
those anticipated and these were usually controlled 
by a reduction in the dosage of the offending drug. 
Although this study suggests that retinoids might 
be beneficial in the management of MF, more pa- 
tients need to be studied and long-term follow-up 
is essential (only 1 patient was treated for a year or 
longer). 
PEARON G. LANG, JR., M.D. 
Rhodamine-123 as a New Photochemosensitizing 
Agent with Argon Laser. “Nonthermal” and Ther- 
mal Effects on Human Squamous Carcinoma Cells 
in Vitro. DJ Castro, RE Saxton, HR Fetterman, et 
al. Laryngoscope 97:554-561, 1987. 
Photodynamic therapy (PDT) to manage cancer has 
recently received much attention. One major draw- 
back, however, is that the photosensitizing agents 
used make the patient extremely photosensitive. In 
order to circumvent this problem, the authors stud- 
ied the effect of the argon laser on cultured human 
squamous cell carcinoma cells (SCC) which had 
been incubated with non-toxic doses of Rhoda- 
mine-123 (Rh-123). Rh-123 is a mitrochondrial spe- 
cific dye which is non-photosensitizing and has a 
peak absorption at 511 nm. The authors found that 
when SCC cells were incubated with Rh-123 there 
was an enhancement of the tumoricidal effect of the 
argon laser. How useful this methodology will be 
when applied to the clinical situation, however, re- 
mains to be demonstrated. 
PEARON G. LANG, JR., M.D. 





Erythromycin is an antibiotic produced from a strain of 
Streptomyces erythraeus. It is basic and readily forms 
salts with acids. Each ml of ERYCETTE (erythromycin 
2%) Topical Solution contains 20 mg of erythromycin 
base in a vehicle consisting of alcohol (66%) and 
propylene glycol. It may contain citric acid to adjust pH. 
Actions 
Although the mechanism by which ERYCETTE 
Solution acts in reducing inflammatory lesions of acne 
vulgaris is unknown, it is presumably due to its 
antibiotic action. 
Indications 
ERYCETTE Solution is indicated for the topical control 
of acne vulgaris. 
Contraindicakns 
ERYCETTE Solution is contraindicated in persons 
who have shown hypersensitivity to any of its 
ingredients. 
Precautionr 
Genera/: The use of antibiotic agents may be 
associated with the overgrowth of antibiotic-resistant 
organisms. If this occurs. administration of this drug 
should be discontinued and appropriate measures 
taken. 
lnformation for Patients: ERYCETTE Solution is for 
external use only and should be kept away from the 
eyes, nose, mouth, and other mucous membranes. 
Concomitant topical acne therapy should be 
used with caution because a cumulative imtant 
effect may occur, especially with the use of peeling, 
desquamating. or abrasive agents. 
Carcinogenesis, Mutagenesis, Impairment of 
fertility: Long-term animal studies to evaluate 
carcinogenic potential, mutagenicity, or the effect on 
fertility of erythromycin have not been performed. 
Pregnancy: Pregnancy Category C. Animal 
reproduction studies have not been conducted with 
erythromycin. It is also not known whether 
erythromycin can cause fetal harm when 
administered to a pregnant woman or can affect 
reproduction capacity. Erythromycin should be given 
to a pregnant woman only if clearly needed. 
Nursing Mothers: It is not known whether 
erythromycin is excreted in human milk after topical 
application. However, this is reported to occur 
with oral and parenteral administration. Therefore, 
caution should be exercised when erythromycin is 
administered to a nursing woman. 
MvermReactkm: 
Adverse conditions reported include dryness, 
tenderness, pruritus, desquamation, erythema, 
oiliness, and burning sensation. Irritation of the eyes 
has also been reported. A case of generalized 
urticaria1 reaction, possibly related to the drug, which 
required the use of systemic steroid therapy has been 
reported. 
R e X C E T T E  pledget should be rubbed over the 
affected area twice a day after the skin is thoroughly 
washed with warm water and soap and patted dry. 
Acne lesions on the face, neck, shoulder, chest, and 
back may be treated in this manner. Additional 
pledgets may be used, if needed. 
and Administration: 
How supplied: 
ERYCETTE (erythromycin 2%) Topical Solution is 
supplied as foil-covered saturated pledgets (swabs) in 
boxes of 60 (NDC0062-1185-01). 
Store at controlled room temperature (59986°F). 
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Subungual Melanoma: A 25-Year Review of Cases. 
JM Daly, R Berlin, C Urmacher. J Surg Oncol 
35~107-112, 1987. 
A retrospective study looking at the clinical path- 
ologic stage of disease in 33 patients with subun- 
gual melanoma was evaluated from patients seen 
at Memorial Sloan-Kettering Cancer Center be- 
tween the years 1950 to 1975. Females (22 )  outnum- 
bered males (11) and the tumors were equally dis- 
tributed between the hand and foot. The most 
common anatomic locations were the thumb and 
large toe. Of 16 patients with hand subungual dis- 
ease, 11 were stage I and 3 were stage 11. None of 
the stage I individuals undergoing elective node 
dissection had microscopic evidence of disease 
where as all of the stage I1 patients had lymph node 
involvement. Seventeen patients had toes subun- 
gual melanomas, 10 were clinically stage I and 7 
were clinically stage 11. Of 9 stage I patients 
undergoing lymph node dissection, 3 had micro- 
scopic lymph node disease. The 5- and 10-year sur- 
vivals were 66 and 55% for clinical stage I disease 
versus 22 and 0% for clinical stage I1 disease. Path- 
ologic stage I disease showed 5- and 10-year sur- 
vivals of 79 and 61% versus 18 and 9% for stage I1 
disease. Site did not influence survival when con- 
trolled for pathologic stage. Histologic grading was 
attempted, but no firm conclusions could be drawn 
except that the thicker tumors appear to have a 
worse prognosis. Prognosis was closely related to 
the clinical/pathologic stage of the disease. 
R. STEVEN PADILLA, M.D. 
Excision of Large Basal Cell Carcinomas - Prob- 
lems and Planning. H Breuninger. Z. Hautkr 
62269-279, 1987 (German). 
During the excision of 1083 basal cell carcinomas, 
the clinically detectable diameters and the safe mar- 
gins along the tumor border were calculated. The 
excision edges were histologically controlled. 115 
of the 1083 tumors showed diameters exceeding 
20 mm. The frequency of excisions with negative or 
positive edges corresponded to the safe margin and 
depth of the incision. The results showed that even 
for large tumors a safe margin of more than 5 mm 
is seldom appropriate or necessary. The excision 
should always include the subcutaneous tissue as 
well as the underlying tissue, if the stite of the 
lesion permits it. The excised edges should be 
histologically controlled if radical excision is 
contemplated. 
YEHUDI M.  FELMAN, M.D. 
1. Dermatol. Surg. Oncol. 13:lU October 1987 
